Related content

Optimal Allocation of Sample Sizes to Multicenter Clinical Trials

By Lai Dejian   Chang Kuang-Chao   Rahbar Mohammad H.   Moye Lemuel A.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 4, 2013-07 ,pp. : 818-828

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Review of: “Sample Sizes for Clinical Trials, by S. A. Julious,”

By Assaid Christopher  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 4, 2010-07 ,pp. : 903-905

Taylor & Francis Ltd

Access to resources Recommend Favorite

Dose Finding Designs for Continuous Responses and Binary Utility

By Fedorov Valerii   Wu Yuehui  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1085-1096

Taylor & Francis Ltd

Access to resources Recommend Favorite

Friction-Cost Method as an Alternative to the Human-Capital Approach in Calculating Indirect Costs

By Adis International Limited  

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 103-104

Adis International

Access to resources Recommend Favorite

Bayesian Sample Size Determination for a Clinical Trial with Correlated Continuous and Binary Outcomes

By Stamey James D.   Natanegara Fanni   Seaman John W.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 4, 2013-07 ,pp. : 790-803

Taylor & Francis Ltd

Access to resources Recommend Favorite